Posted by Equitymaster Share markets in India ended the day on a flat note after the Nifty 50 hit the crucial 10,000 mark for the first time ever.... ...http://www.equitymaster.com/tm/tm.asp?date=7/25/2017&title=Nifty-Ends-Flat-After-Hitting-10000-Mark-Where-Should-You-Invest-Now
Drug firm Zydus Cadila today said it has received final approval from US health regulator for generic Mesalamine delayed-release tablets used for... ...http://www.dnaindia.com/business/report-zydus-cadila-gets-usfda-nod-for-its-ulcerative-colitis-drug-2513190
'In any organisation, a continuous line of leadership, is required.' 'All R&D will be of focus. All the way from Active Pharmaceutical Ingredients... ...http://www.rediff.com/money/interview/the-baton-passes-at-zydus-cadilla/20170725.htm
Posted by Equitymaster Share markets in India continued their upward climb in afternoon trade. At the closing bell, the BSE Sensex closed higher by... ...http://www.equitymaster.com/tm/tm.asp?date=7/19/2017&title=Sensex-Finishes-Over-240-Points-Higher-Metal--Healthcare-Stocks-Gain-Most
Indian shares rose on Wednesday, with drugmaker Aurobindo Pharma Ltd up on hopes of higher U.S. sales and consumer staple Hindustan Unilever... ...http://www.sify.com/finance/sensex-rises-as-drugmakers-consumer-stocks-gain-news-sensex-rhtndEaidebag.html
CADILA PHARMACEUTICALS LTD, J.B....
Meher Pharma International provides...